mylanta one antacid/anti-gas

Generic: calcium carbonate, magnesium hydroxide, dimethicone

Labeler: infirst healthcare inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name mylanta one antacid/anti-gas
Generic Name calcium carbonate, magnesium hydroxide, dimethicone
Labeler infirst healthcare inc.
Dosage Form TABLET, CHEWABLE
Routes
ORAL
Active Ingredients

calcium carbonate 1000 mg/1, dimethicone 80 mg/1, magnesium hydroxide 270 mg/1

Manufacturer
Infirst Healthcare Inc.

Identifiers & Regulatory

Product NDC 62372-551
Product ID 62372-551_0c441a11-2c3b-c0ef-e063-6294a90abc86
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M001
Listing Expiration 2026-12-31
Marketing Start 2021-05-04

Pharmacologic Class

Physiologic Effect
skin barrier activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62372551
Hyphenated Format 62372-551

Supplemental Identifiers

RxCUI
2556794
UPC
0072799050276
UNII
H0G9379FGK 92RU3N3Y1O NBZ3QY004S
NUI
N0000010282

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mylanta one antacid/anti-gas (source: ndc)
Generic Name calcium carbonate, magnesium hydroxide, dimethicone (source: ndc)
Application Number M001 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1000 mg/1
  • 80 mg/1
  • 270 mg/1
source: ndc
Packaging
  • 50 TABLET, CHEWABLE in 1 BOTTLE (62372-551-51)
source: ndc

Packages (1)

62372-551-51 50 TABLET, CHEWABLE in 1 BOTTLE (62372-551-51)

Ingredients (3)

calcium carbonate (1000 mg/1) dimethicone (80 mg/1) magnesium hydroxide (270 mg/1)

Linked Drug Pages (1)

Mylanta One Antacid/Anti-Gas ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "0c441a11-2c3b-c0ef-e063-6294a90abc86", "openfda": {"nui": ["N0000010282"], "upc": ["0072799050276"], "unii": ["H0G9379FGK", "92RU3N3Y1O", "NBZ3QY004S"], "rxcui": ["2556794"], "spl_set_id": ["aa694e0d-7891-4870-8106-dd57f1e29fb4"], "pharm_class_pe": ["Skin Barrier Activity [PE]"], "manufacturer_name": ["Infirst Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 TABLET, CHEWABLE in 1 BOTTLE (62372-551-51)", "package_ndc": "62372-551-51", "marketing_start_date": "20210816"}], "brand_name": "Mylanta One Antacid/Anti-Gas", "product_id": "62372-551_0c441a11-2c3b-c0ef-e063-6294a90abc86", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Blood Coagulation Factor [EPC]", "Calcium [CS]", "Calculi Dissolution Agent [EPC]", "Cations", "Divalent [CS]", "Increased Coagulation Factor Activity [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Phosphate Binder [EPC]", "Phosphate Chelating Activity [MoA]", "Skin Barrier Activity [PE]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "62372-551", "generic_name": "Calcium carbonate, Magnesium hydroxide, Dimethicone", "labeler_name": "Infirst Healthcare Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mylanta One Antacid/Anti-Gas", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "1000 mg/1"}, {"name": "DIMETHICONE", "strength": "80 mg/1"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "270 mg/1"}], "application_number": "M001", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210504", "listing_expiration_date": "20261231"}